RUSSIA : Russia has granted approval for clinical trials to be held for the Chinese covid-19 vaccine Ad5-Ncov involving 8,000 volunteers, the Interfax news agency reported on Monday.Ad5-nCoV is a vaccine candidate co-developed by CanSino Biologics and a Chinese military-backed research unit.This story has been published from a wire agency feed without modifications to the text.